Mercedes Porosnicu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Locally Advanced

Metastatic Colorectal Cancer

Top Venues

Therapeutic advances in medical oncology

Future oncology (London, England)

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of medical imaging and radiation oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Kimberly M Burcher, Chance H Bloomer, Elena Gavrila, John M Kalada, Mark J Chang, Rediet R Gebeyehu, Alexander H Song, Lara M Khoury, Thomas W Lycan, Rebecca Kinney, Ralph D'Agostino, Paul M Bunch, Kirtikar Shukla, Pierre Triozzi, Cristina M Furdui, Wei Zhang, Mercedes Porosnicu
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer. Therapeutic advances in medical oncology 16 (2024)
Kimberly M Burcher, Chance H Bloomer, Elena Gavrila, John M Kalada, Mark J Chang, Rediet R Gebeyehu, Alexander H Song, Lara M Khoury, Thomas W Lycan, Rebecca Kinney, Ralph D'Agostino, Paul M Bunch, Kirtikar Shukla, Pierre Triozzi, Cristina M Furdui, Wei Zhang, Mercedes Porosnicu
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer. Therapeutic advances in medical oncology 16 (2024)
Kimberly M Burcher, Chance H Bloomer, Elena Gavrila, John M Kalada, Mark J Chang, Rediet R Gebeyehu, Alexander H Song, Lara M Khoury, Thomas W Lycan, Rebecca Kinney, Ralph D'Agostino, Paul M Bunch, Kirtikar Shukla, Pierre Triozzi, Cristina M Furdui, Wei Zhang, Mercedes Porosnicu
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer. Therapeutic advances in medical oncology 16 (2024)
Chance H Bloomer, Elena Gavrila, Kimberly M Burcher, John M Kalada, Mark J Chang, Rediet R Gebeyehu, Elsabeth Asare, Lara M Khoury, Rebecca Kinney, Bart Frizzell, Christopher A Sullivan, Paul M Bunch, Mercedes Porosnicu
Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature. Therapeutic advances in medical oncology 15 (2023)
Chance H Bloomer, Elena Gavrila, Kimberly M Burcher, John M Kalada, Mark J Chang, Rediet R Gebeyehu, Elsabeth Asare, Lara M Khoury, Rebecca Kinney, Bart Frizzell, Christopher A Sullivan, Paul M Bunch, Mercedes Porosnicu
Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature. Therapeutic advances in medical oncology 15 (2023)
Ryan T Hughes, Rediet R Gebeyehu, John Mason Kalada, Thomas W Lycan, Bart A Frizzell, Rebecca D Kinney, Ralph B D'Agostino, Paul M Bunch, Pierre L Triozzi, Wei Zhang, Cristina M Furdui, Mercedes Porosnicu
Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer. Future oncology (London, England) (2023)
Mercedes Porosnicu, Anne-Marie Quinson, Kate Crossley, Stephan Luecke, Ulrich M Lauer
Phase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumors. Future oncology (London, England) 18 (24) (2022)
Lara M Khoury, Kimberly M Burcher, Ronald T Ng, Alexander H Song, Mark J Chang, Elena Gavrila, Chance H Bloomer, Mac B Robinson, Brian E Kouri, Joshua D Waltonen, Paul M Bunch, Ulrich M Lauer, Mercedes Porosnicu
Serendipitous synergism - an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature. Therapeutic advances in medical oncology 14 (2022)
Charu Aggarwal, Nabil F Saba, Alain Patrick Algazi, Ammar Sukari, Tanguy Y Seiwert, Missak Haigentz, Mercedes Porosnicu, Marcelo R Bonomi, Jean Boyer, Mark T Esser, Lily I Cheng, Sonia Agrawal, Emily C Jennings, Nicholas M Durham, Karl Fraser, Delphine Lissa, Maozhen Gong, Natalia Ceaicovscaia, Amaya Gasco Hernandez, Rakesh Kumar
Safety and Efficacy of MEDI0457 Plus Durvalumab in Patients With Human Papillomavirus-associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Ryan T Hughes, Mercedes Porosnicu, Beverly J Levine, Thomas W Lycan, Rachel F Shenker, Bart A Frizzell, Kathryn M Greven
Chemoradiotherapy with high-dose cisplatin compared with weekly cisplatin for locally advanced head and neck squamous cell carcinoma. Journal of medical imaging and radiation oncology 65 (6) (2021)